Press Releases

Active Biotech AB Interim report January - March 2010
April 22, 2010 08:30 (CEST)
Annual Report 2009 Active Biotech AB (publ)
April 20, 2010 10:05 (CEST)
NEW DATA SUGGEST ORAL LAQUINIMOD MAY CONFER NEUROPROTECTION IN ADDITION TO IMMUNOMODULATION IN THE TREATMENT OF MULTIPLE SCLEROSIS
April 15, 2010 18:29 (CEST)
Notice of Annual General Meeting of Shareholders
April 6, 2010 08:30 (CEST)
Active Biotech raises SEK 149 million through a directed share issue
April 1, 2010 15:00 (CEST)
Number of shares and votes in Active Biotech
March 31, 2010 16:00 (CEST)
Number of shares and votes in Active Biotech
February 26, 2010 08:30 (CET)
Active Biotech AB Year-end Report, January - December 2009
February 11, 2010 08:30 (CET)
Exploratory data presented for Active Biotech's ANYARA project
February 10, 2010 20:02 (CET)
TEVA ACQUIRES MARKETING RIGHTS FOR ORAL LAQUINIMOD IN THE NORDIC AND BALTIC REGIONS
February 8, 2010 14:30 (CET)